Clinical trial NCT02781441: Evaluation of a Question Prompt List for Patients With Myelodysplastic Syndromes (QPL-MDS)
Official title: Evaluation of a Question Prompt List for Patients With Myelodysplastic Syndromes (QPL-MDS)
Study type: INTERVENTIONAL
Overall status: UNKNOWN
Phase: NA
Conditions: Myelodysplastic Syndromes
Lead sponsor: Institut Paoli-Calmettes
Sponsor class: OTHER
First posted: 2016-05-24
Enrollment: 140
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: HEALTH_SERVICES_RESEARCH

Brief summary: MDS are a diverse group of hematopoietic malignancies, which mainly occur in patients over 75 years of age. Incidence rate in 2012 in France was more than 6 cases per 100 000 person-years. MDS are characterized by ineffective haematopoiesis causing cytopenia, and by leukemic transformation. The disease is heterogeneous, its pathophysiology complex and clinical evolution variable.The few data available on MDS patients show how difficult it is to understand MDS, its prognosis and the reasons for prescribing or not some treatments. In the context of a highly complex potentially lethal disease such as MDS, it is of utmost importance to optimize the information conveyed to patients. Particularly, 70.5% of MDS patients surveyed in our developmental study would have preferred more information about prognosis at diagnosis disclosure.

A simple intervention based on the use of a question prompt list (QPL), would greatly improve the information process by helping patients to express their main concerns at their medical consultations. Cultural differences may exist in the appraisal of QPLs and QPLs have not yet been widely used in France.

However, in line with the previous results available in the literature and in a context a priori favourable to the use of such an instrument, the investigators hypothesise that use of a QPL will increase MDS patients' expressions of concerns and questions at their medical consultations. Particularly the investigators assume that the discussion about prognosis will be facilitated, without increasing anxiety because patients remain free to ask or not for such information. The use of QPLs would also be a way to limit social inequalities related to insufficient information and to encourage patient-doctor communication and meeting of patient preferences which could lead to better health outcomes.


Eligibility criteria: Inclusion Criteria:

* Patients newly referred for a MDS in one of the participating centres
* Older than 18
* Able to answer a self-administered questionnaire
* Having signed an informed consent
* affiliated to the French Social Security System

Exclusion Criteria:

* emergency,patients deprived of liberty or placed under the authority of a tutor

Primary outcomes:
measure: Patients having discussed as they wished about the prognosis of their MDS in the next medical consultation
timeFrame: 17 months
Secondary outcomes:
measure: number of questions and concerns expressed in each content category covered by the QPL (including prognosis)
timeFrame: 17 months
measure: Duration of the recorded consultation
timeFrame: 17 months
measure: Quality of life
timeFrame: 17 months
measure: Anxiety
timeFrame: 17 months
measure: Satisfaction with the provided information
timeFrame: 17 months
Other outcomes:
Locations:
city: Grenoble
country: France
facility: Chu Grenoble
city: Marseille
country: France
facility: Institut Paoli-Calmettes
Study officials:
affiliation: Institut Paoli-Calmettes
name: Jérôme Rey, MD
role: PRINCIPAL_INVESTIGATOR
References: